Total Payments
$5,713
2024 Payments
$1,608
Companies
28
Transactions
272
Medicare Patients
1,050
Medicare Billing
$166,125
Payment Breakdown by Category
Food & Beverage$5,713 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,713 | 272 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,142 | 58 | $0 (2024) |
| QOL Medical, LLC | $1,122 | 47 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $466.70 | 23 | $0 (2024) |
| Ardelyx, Inc. | $354.91 | 18 | $0 (2024) |
| Celgene Corporation | $311.70 | 17 | $0 (2024) |
| PFIZER INC. | $272.44 | 11 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $249.19 | 14 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $239.30 | 7 | $0 (2024) |
| Novo Nordisk Inc | $237.71 | 13 | $0 (2024) |
| Janssen Biotech, Inc. | $210.62 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,608 | 71 | QOL Medical, LLC ($350.10) |
| 2023 | $2,227 | 106 | QOL Medical, LLC ($568.56) |
| 2022 | $764.52 | 35 | ABBVIE INC. ($308.42) |
| 2020 | $423.17 | 24 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($86.33) |
| 2019 | $476.56 | 29 | QOL Medical, LLC ($133.55) |
| 2018 | $13.12 | 1 | Intercept Pharmaceuticals, Inc. ($13.12) |
| 2017 | $201.19 | 6 | Intercept Pharmaceuticals, Inc. ($127.96) |
All Payment Transactions
272 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Obesity | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Immunology | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $26.51 | General |
| 12/10/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $3.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/25/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $25.87 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.37 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: LIVER DISEASE | ||||||
| 10/31/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.11 | General |
| 10/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/18/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $30.03 | General |
| Category: THERAPY FOR CSID | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 359 | 415 | $401,525 | $50,978 |
| 2022 | 9 | 332 | 371 | $312,525 | $53,037 |
| 2021 | 8 | 233 | 271 | $186,675 | $43,051 |
| 2020 | 5 | 126 | 155 | $78,650 | $19,059 |
Total Patients
1,050
Total Services
1,212
Medicare Billing
$166,125
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 109 | 151 | $37,750 | $16,077 | 42.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 27 | 27 | $67,500 | $6,277 | 9.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $16,625 | $5,260 | 31.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 18 | 18 | $27,000 | $4,619 | 17.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 28 | $18,200 | $4,451 | 24.5% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2023 | 21 | 21 | $42,000 | $2,793 | 6.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 11 | 11 | $27,500 | $2,426 | 8.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 32 | 36 | $54,000 | $2,121 | 3.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 41 | 41 | $61,500 | $1,972 | 3.2% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 13 | 14 | $28,000 | $1,933 | 6.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 11 | 11 | $16,500 | $1,707 | 10.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 22 | $4,950 | $1,342 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 136 | $34,000 | $14,778 | 43.5% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Office | 2022 | 20 | 20 | $40,000 | $9,307 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 41 | 41 | $19,475 | $5,994 | 30.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 25 | 25 | $37,500 | $5,777 | 15.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 25 | 25 | $62,500 | $5,318 | 8.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 33 | 33 | $49,500 | $4,959 | 10.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 17 | $11,050 | $2,603 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 20 | $4,500 | $1,444 | 32.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $25,500 | $1,286 | 5.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $25,500 | $1,126 | 4.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 20 | 20 | $3,000 | $445.36 | 14.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 69 | 101 | $25,250 | $11,281 | 44.7% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Office | 2021 | 32 | 32 | $48,000 | $8,930 | 18.6% |
About Dr. Amy Tan, MD
Dr. Amy Tan, MD is a Gastroenterology healthcare provider based in Garden City, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2013. The National Provider Identifier (NPI) number assigned to this provider is 1932542149.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Tan, MD has received a total of $5,713 in payments from pharmaceutical and medical device companies, with $1,608 received in 2024. These payments were reported across 272 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($5,713).
As a Medicare-enrolled provider, Tan has provided services to 1,050 Medicare beneficiaries, totaling 1,212 services with total Medicare billing of $166,125. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Garden City, NY
- Active Since 04/08/2013
- Last Updated 05/06/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1932542149
Products in Payments
- Sucraid (Drug) $772.26
- RINVOQ (Biological) $486.02
- IBSRELA (Drug) $354.91
- SUCRAID (Drug) $350.10
- ENTYVIO (Biological) $328.77
- ZEPOSIA (Drug) $311.70
- XELJANZ (Drug) $247.48
- DUPIXENT (Biological) $230.07
- Linzess (Drug) $201.22
- XIFAXAN (Drug) $174.85
- SKYRIZI (Biological) $170.28
- OCA (Drug) $127.96
- CREON (Drug) $122.10
- STELARA (Biological) $109.70
- TREMFYA (Drug) $100.92
- OCALIVA (Drug) $96.65
- VIBERZI (Drug) $91.93
- Talicia (Drug) $88.06
- LINZESS (Drug) $76.77
- HUMIRA (Biological) $67.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Garden City
Dr. Eleazer Yousefzadeh, M.d, M.D
Gastroenterology — Payments: $51,588
Gastroenterology $51,588
Dr. Sridevi Bhumi, M.d, M.D
Gastroenterology — Payments: $17,485
Gastroenterology $17,485
Dr. Chris Demetriou, M.d, M.D
Gastroenterology — Payments: $14,084
Gastroenterology $14,084
Robert Bartolomeo, M.d, M.D
Gastroenterology — Payments: $5,692
Gastroenterology $5,692
Eugene Sullivan, D.o, D.O
Gastroenterology — Payments: $4,777
Gastroenterology $4,777
Jennifer Miller, Do, DO
Gastroenterology — Payments: $2,841
Gastroenterology $2,841